Stockreport

Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet T...

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF AZALEA-TIMI 71 is the largest head-to-head study of a factor XI inhibitor against a direct-oral anticoagulant CAMBRIDGE, Mass., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Anth [Read more]